SJL Partners
Investment Details
Investor Type
Private Equity
Asset Class Focus
Private Equity
Stage Focus
Growth, Buyout
Geographical Focus
United States, United Kingdom, Canada, Germany, France, Italy, Denmark, Switzerland, Spain, Luxembourg, Ireland, Austria, Netherlands, Portugal, Sweden, Belgium, Norway, Finland, Poland, Czech Republic
Industries Focus
- Financial Services
- Technology
- Healthcare
- Energy
- Consumer Goods
- Real Estate
- Telecommunications
- Media
- Retail
- Education
- Agriculture
- Transportation
- Pharmaceuticals
- Biotechnology
- Industrial Goods
Investment Size:
1,000,000,000 to 3,100,000,000 USD
Investor Details Founded: 2017
SJL Partners is a private equity investment manager based in Seoul, Korea, focusing on cross-border investments primarily in North America and Europe. The firm collaborates with strategic partners from Asia to leverage synergies and mitigate risks, aiming to create value through outbound cross-border opportunities. Their expertise lies in executing cross-border mergers and acquisitions, operational improvements, and governance enhancements.
The firm's investment strategy targets growth and buyout stages, with a particular emphasis on sectors such as healthcare, technology, consumer goods, industrial goods, energy, financial services, media, telecommunications, transportation, real estate, retail, education, agriculture, pharmaceuticals, and biotechnology. SJL Partners seeks to partner with market-leading strategic companies to support their organic and inorganic growth, including bolt-on acquisitions.
Since its founding in 2017, SJL Partners has completed several significant transactions, including a US$1.55 billion joint acquisition of Meridian Bioscience with SD Biosensor in 2023, a US$3.1 billion joint acquisition of Momentive Performance Materials with KCC Corporation and Wonik QnC Corporation in 2019, and a US$100 million investment into Vigevano in 2018. These milestones reflect the firm's commitment to delivering substantial value creation opportunities in cross-border M&As within OECD markets.
Requirements
- Partnership with strategic Asian investors
- Focus on cross-border M&A opportunities
- Emphasis on value creation through synergies and risk mitigation
Contact
[Official Website Hidden]
[HQ Location Hidden]
[Email Hidden]
[Contact Number Hidden]
Portfolio Companies
- Meridian Bioscience
- Momentive Performance Materials
- Vigevano
Mentioned In
-
$24.95
-
$19.95
-
$19.95
-
$19.95
-
$9.95
-
$19.95
-
$9.95
-
$99.00
-
$19.95
-
$39.95
-
$99.00
Claim this Investor
Are you an official representative of SJL Partners?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim